News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
APPLE ROBERT F
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/18/2022 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Granted 76,893 shares
@ $0 Paid exercise price by delivering 34,282 shares
@ $3.66, valued at
$125.5k
|
|
06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/15/2020 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Granted 402,930 shares
@ $2.73, valued at
$1.1M
Paid exercise price by delivering 40,892 shares
@ $2.78, valued at
$113.7k
Granted 776,617 options to buy
@ $2.73, valued at
$2.1M
|
|
06/09/2020 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Paid exercise price by delivering 48,936 shares
@ $3.12, valued at
$152.7k
Paid exercise price by delivering 44,223 shares
@ $3.13, valued at
$138.4k
|
|
02/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/11/2019 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Sold 100,000 shares
@ $4.6783, valued at
$467.8k
Sold 97,000 shares
@ $4.6228, valued at
$448.4k
Sold 110,000 shares
@ $4.5766, valued at
$503.4k
Sold 1,000 shares
@ $4.75, valued at
$4.8k
Sold 58,524 shares
@ $4.7563, valued at
$278.4k
Exercised 100,000 options to buy
@ $1.52, valued at
$152k
Exercised 97,000 options to buy
@ $1.66, valued at
$161k
Exercised 110,000 options to buy
@ $2.94, valued at
$323.4k
Exercised 1,000 options to buy
@ $3.96, valued at
$4k
Exercised 58,524 options to buy
@ $3.96, valued at
$231.8k
|
|
11/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2019 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Granted 282,534 shares
@ $2.92, valued at
$825k
Granted 567,423 options to buy
@ $2.92, valued at
$1.7M
|
|
06/11/2019 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Paid exercise price by delivering 48,936 shares
@ $2.81, valued at
$137.5k
Paid exercise price by delivering 44,225 shares
@ $2.81, valued at
$124.3k
|
|
06/04/2019 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Paid exercise price by delivering 52,559 shares
@ $2.79, valued at
$146.6k
|
|
02/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/23/2018 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Sold 43,000 shares
@ $3.75, valued at
$161.3k
Exercised 43,000 options to buy
@ $0.47, valued at
$20.2k
|
|
06/11/2018 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Paid exercise price by delivering 32,031 shares
@ $2.7, valued at
$86.5k
Granted 305,556 shares
@ $2.7, valued at
$825k
Granted 591,510 options to buy
@ $2.7, valued at
$1.6M
|
|
06/05/2018 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Paid exercise price by delivering 34,402 shares
@ $2.69, valued at
$92.5k
|
|
05/30/2018 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Paid exercise price by delivering 13,480 shares
@ $2.43, valued at
$32.8k
|
|
05/14/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/26/2018 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Granted 113,835 shares
@ $0 Paid exercise price by delivering 37,001 shares
@ $2.2, valued at
$81.4k
|
|
06/12/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
06/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/05/2017 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Sold 37,000 shares
@ $3.0019, valued at
$111.1k
Sold 3,000 shares
@ $3, valued at
$9k
Exercised 37,000 options to buy
@ $1.65, valued at
$61.1k
Exercised 3,000 options to buy
@ $1.65, valued at
$5k
|
|
12/29/2016 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Exercised 60,000 shares
@ $1.23, valued at
$73.8k
Paid exercise price by delivering 39,717 shares
@ $2.35, valued at
$93.3k
Exercised 60,000 options to buy
@ $1.23, valued at
$73.8k
|
|
06/30/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/06/2016 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Granted 363,150 shares
@ $1.12, valued at
$406.7k
Granted 773,700 options to buy
@ $1.12, valued at
$866.5k
|
|
06/01/2016 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Paid exercise price by delivering 3,526 shares
@ $0.86, valued at
$3k
Paid exercise price by delivering 14,903 shares
@ $0.92, valued at
$13.7k
Paid exercise price by delivering 3,389 shares
@ $0.92, valued at
$3.1k
|
|
03/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/11/2016 |
4
| APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Granted 250,000 options to buy
@ $0.88, valued at
$220k
|
|
10/16/2013 |
4
| APPLE ROBERT F (Executive Vice President & CFO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Sold 22,000 shares
@ $5.0545, valued at
$111.2k
Exercised 22,000 options to buy
@ $0.47, valued at
$10.3k
|
|
06/05/2013 |
4
| APPLE ROBERT F (Executive Vice President & CFO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns:
| Sold 86,400 shares
@ $4.0138, valued at
$346.8k
Sold 28,600 shares
@ $4.0254, valued at
$115.1k
Exercised 86,400 options to buy
@ $0.47, valued at
$40.6k
Exercised 28,600 options to buy
@ $0.47, valued at
$13.4k
|
|
|
|
|